Chronic myelogenous leukemia following repeated radiation therapy for histiocytosis x

Linnea Chap; Stephen D. Nimer

doi:10.3109/10428199409059604

Chronic myelogenous leukemia following repeated radiation therapy for histiocytosis x

Linnea Chap, Stephen D. Nimer

Research output: Contribution to journal › Article

12 Scopus citations

Abstract

Low dose radiotherapy has been used to treat a variety of benign disorders including Histiocytosis X. Ionizing radiation may be leukemogenic with leukemia developing between 3.5 to 11 years after exposure. Twenty to 30% of these leukemias are chronic myelogenous leukemia (CML). In this report the rare development of PH1 + CML 11 years after radiation therapy for Histiocytosis X is recorded.

Original language	English (US)
Pages (from-to)	315-316
Number of pages	2
Journal	Leukemia and Lymphoma
Volume	12
Issue number	3-4
DOIs	https://doi.org/10.3109/10428199409059604
State	Published - Jan 1 1994
Externally published	Yes

Keywords

CML
Histiocytic disorders
Histiocytosis X
Radiation-induced malignancies

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.3109/10428199409059604

Fingerprint Dive into the research topics of 'Chronic myelogenous leukemia following repeated radiation therapy for histiocytosis x'. Together they form a unique fingerprint.

Cite this

Chap, L., & Nimer, S. D. (1994). Chronic myelogenous leukemia following repeated radiation therapy for histiocytosis x. Leukemia and Lymphoma, 12(3-4), 315-316. https://doi.org/10.3109/10428199409059604

@article{b25d046faf56446d9b1ce86ae73f0030,

title = "Chronic myelogenous leukemia following repeated radiation therapy for histiocytosis x",

abstract = "Low dose radiotherapy has been used to treat a variety of benign disorders including Histiocytosis X. Ionizing radiation may be leukemogenic with leukemia developing between 3.5 to 11 years after exposure. Twenty to 30% of these leukemias are chronic myelogenous leukemia (CML). In this report the rare development of PH1 + CML 11 years after radiation therapy for Histiocytosis X is recorded.",

keywords = "CML, Histiocytic disorders, Histiocytosis X, Radiation-induced malignancies",

author = "Linnea Chap and Nimer, {Stephen D.}",

year = "1994",

month = jan,

day = "1",

doi = "10.3109/10428199409059604",

language = "English (US)",

volume = "12",

pages = "315--316",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "3-4",

}

TY - JOUR

T1 - Chronic myelogenous leukemia following repeated radiation therapy for histiocytosis x

AU - Chap, Linnea

AU - Nimer, Stephen D.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Low dose radiotherapy has been used to treat a variety of benign disorders including Histiocytosis X. Ionizing radiation may be leukemogenic with leukemia developing between 3.5 to 11 years after exposure. Twenty to 30% of these leukemias are chronic myelogenous leukemia (CML). In this report the rare development of PH1 + CML 11 years after radiation therapy for Histiocytosis X is recorded.

AB - Low dose radiotherapy has been used to treat a variety of benign disorders including Histiocytosis X. Ionizing radiation may be leukemogenic with leukemia developing between 3.5 to 11 years after exposure. Twenty to 30% of these leukemias are chronic myelogenous leukemia (CML). In this report the rare development of PH1 + CML 11 years after radiation therapy for Histiocytosis X is recorded.

KW - CML

KW - Histiocytic disorders

KW - Histiocytosis X

KW - Radiation-induced malignancies

UR - http://www.scopus.com/inward/record.url?scp=0028266416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028266416&partnerID=8YFLogxK

U2 - 10.3109/10428199409059604

DO - 10.3109/10428199409059604

M3 - Article

C2 - 8167563

AN - SCOPUS:0028266416

VL - 12

SP - 315

EP - 316

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 3-4

ER -